Phospholipase C-γ1 expression correlated with cancer progression of potentially malignant oral lesions

Journal of Oral Pathology and Medicine

Volumn 42, Issue 1, 2013, Pages 47-52

  Ma, Li Wei ^a   Zhou, Zeng Tong ^a   He, Qing Bo ^a   Jiang, Wei Wen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Malignant transformation; Oral potentially malignant lesion; Oral squamous cell carcinoma; Phospholipase C 1, biomarker

Indexed keywords

PHOSPHOLIPASE C GAMMA1;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PHOSPHOLIPASE C GAMMA; PRECANCEROUS CONDITIONS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; RISK FACTORS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84871936919     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01179.x     Document Type: Article

References (28)

1. Warnakulasuriya S. Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol 2010; 46: 407-10.
2. Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med 2010; 39: 299-305.
3. Ganly I, Patel S, Shah J. Early stage squamous cell cancer of the oral tongue- clinicopathologic features affecting outcome. Cancer 2011; 118: 101-11.
4. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 2010; 46: 423-5.
5. Pitiyage G, Tilakaratne WM, Tavassoli M, Warnakulasuriya S. Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med 2009; 38: 737-52.
6. Smith J, Rattay T, McConkey C, Helliwell T, Mehanna H. Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol 2009; 45: 647-53.
7. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck 2009; 31: 1600-9.
8. Nankivell P, Mehanna H. Oral Dysplasia: Biomarkers, Treatment, and Follow-up. Curr Oncol Rep 2011; 13: 145-52.
9. Lingen MW, Pinto A, Mendes RA, et al. Genetics/epigenetics of oral premalignancy: current status and future research. Oral Dis 2011; 17(Suppl. 1): 7-22.
10. Wu RQ, Zhao XF, Wang ZY, Zhou M, Chen QM. Novel molecular events in oral carcinogenesis via integrative approaches. J Dent Res 2011; 90: 561-72.
11. Wells A, Grandis JR. Phospholipase C-γ1 in tumor progression. Clin Exp Metastasis 2003; 20: 285-90.
12. Sala G, Dituri F, Raimondi C, et al. Phospholipase Cγ1 is required for metastasis development and progression. Cancer Res 2008; 68: 10187-96.
13. Szabó B, Nelhubel GA, Kárpáti A, et al. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. Oral Oncol 2011; 47: 487-96.
14. Sheu JJ, Hua CH, Wan L, et al. Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma. Cancer Res 2009; 69: 2568-76.
15. Wu HG, Song SY, Kim YS, et al. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial. Cancer 2009; 115: 3699-708.
16. Sharafinski ME, Ferris RL, Ferrone S, Grandis JR. Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head Neck 2010; 32: 1412-21.
17. Taoudi Benchekroun M, Saintigny P, Thomas SM, et al. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res 2010; 3: 800-9.
18. Shepard CR, Kassis J, Whaley DL, Kim HG, Wells A. PLCγ contributes to metastasis of in situ-occurring mammary and prostate tumors. Oncogene 2007; 26: 3020-6.
19. Kang JK, Chang CH, Nam HJ, et al. Downregulation of erythropoietin receptor by overexpression of phospholipase C-gamma 1 is critical for decrease on focal adhesion in transformed cells. Cell Oncol 2011; 34: 11-21.
20. Xie Z, Chen Y, Liao EY, Jiang Y, Liu FY, Pennypacker SD. Phospholipase C-gamma1 is required for the epidermal growth factor receptor-induced squamous cell carcinoma cell mitogenesis. Biochem Biophys Res Commun 2010; 397: 296-300.
21. Nozawa H, Howell G, Suzuki S, et al. Combined inhibition of PLCγ-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion. Clin Cancer Res 2008; 14: 4336-44.
22. Thomas SM, Coppelli FM, Wells A, et al. Epidermal growth factor receptor-stimulated activation of phospholipase C -1 promotes invasion of head and neck squamous cell carcinoma. Cancer Res 2003; 63: 5629-35.
23. Beloueche-Babari M, Peak JC, Jackson LE, Tiet MY, Leach MO, Eccles SA. Changes in choline metabolism as potential biomarkers of phospholipase C{gamma}1 inhibition in human prostate cancer cells. Mol Cancer Ther 2009; 8: 1305-11.
24. Torres-Rendon A, Roy S, Craig GT, Speight PM. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas. Br J Cancer 2009; 100: 1128-34.
25. Montebugnoli L, Cervellati F, Cocchi R, et al. Immunohistochemical expression of p16(INK4A) protein as a helpful marker of a subset of potentially malignant oral epithelial lesions: study on a series with long-term follow-up. Histopathology 2010; 57: 528-34.
26. Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT, Tang GY. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer 2010; 10: 685.
27. Ogbureke KU, Abdelsayed RA, Kushner H, Li L, Fisher LW. Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma. Cancer 2010; 116: 1709-17.
28. Liu W, Feng JQ, Shen XM, Wang HY, Liu Y, Zhou ZT. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study. Cancer 2012; 118: 1693-700.